{
	"kja6j3nwText": "Cip<span class=\"_ _c\"></span>rian<span class=\"_ _c\"></span>i A et al. 2<span class=\"_ _c\"></span>0<span class=\"_ _c\"></span>1<span class=\"_ _3\"></span>8<span class=\"_ _3\"></span><span class=\"fs1 v1\">1</span>",
	"kja6j3nxText": "Large<span class=\"_ _2\"></span>, inde<span class=\"_ _2\"></span>pende<span class=\"_ _2\"></span>nt nerwork meta-ana<span class=\"_ _2\"></span>lysis wh<span class=\"_ _2\"></span>ich an<span class=\"_ _2\"></span>alysed 5<span class=\"_ _3\"></span>22 tria<span class=\"_ _2\"></span>ls and 1<span class=\"_ _23\"></span>1<span class=\"_ _3\"></span>6,4<span class=\"_ _c\"></span>77 pa<span class=\"_ _2\"></span>tien<span class=\"_ _2\"></span>ts<span class=\"_ _0\"></span> <br>in the acut<span class=\"_ _2\"></span>e treatme<span class=\"_ _2\"></span>nt of adu<span class=\"_ _2\"></span>lts with MDD<span class=\"_ _c\"></span>, to comp<span class=\"_ _2\"></span>are the effcac<span class=\"_ _0\"></span>y and ac<span class=\"_ _2\"></span>ceptab<span class=\"_ _2\"></span>ility of 2<span class=\"_ _2\"></span>1 <br><span class=\"ls4b ws5c\">antidepres<span class=\"_ _0\"></span>sant<span class=\"_ _0\"></span>s<span class=\"_ _0\"></span>.</span>",
	"kja6j3nyText": "Large network meta-an<span class=\"_ _2\"></span>alyses a<span class=\"_ _2\"></span>llo<span class=\"_ _2\"></span>w a co<span class=\"_ _2\"></span>mpari<span class=\"_ _2\"></span>son of tre<span class=\"_ _2\"></span>atments (<span class=\"_ _c\"></span>or nod<span class=\"_ _2\"></span>es in the n<span class=\"_ _2\"></span>et<span class=\"_ _0\"></span>wor<span class=\"_ _2\"></span>k) <br>that ar<span class=\"_ _2\"></span>e not di<span class=\"_ _2\"></span>rectly compa<span class=\"_ _2\"></span>red with a d<span class=\"_ _2\"></span>irect s<span class=\"_ _0\"></span>tudy<span class=\"_ _c\"></span>.",
	"kja6j3nzText": "522 randomised <br>clinical trials<span class=\"_ _0\"></span> <br><span class=\"ws81\">including <br>placebo-controlled <br></span>and head-to-head<span class=\"_ _0\"></span> <br>studies of 21<span class=\"_ _0\"></span> <br><span class=\"ws9\">antidepressants</span>",
	"kja6j3o0Text": "Outcomes were <br>recorded as close <br>to 8 weeks as <br>possible for all<span class=\"_ _0\"></span> <br>analyses",
	"kja6j3o1Text": "Outcomes: ",
	"kja6j3o2Text": "Efficacy (response r<span class=\"_ _2\"></span>ate ",
	"kja6j3o3Text": "measured by the total ",
	"kja6j3o4Text": "number of patients who had ",
	"kja6j3o5Text": "a reduction of ≥50% of the ",
	"kja6j3o6Text": "total score on a standardised ",
	"kja6j3o7Text": "observer-ra<span class=\"_ _2\"></span>ting scale for ",
	"kja6j3o8Text": "depression) and acceptability ",
	"kja6j3o9Text": "(treatment discontinua<span class=\"_ _2\"></span>tion ",
	"kja6j3oaText": "measured by the pr<span class=\"_ _2\"></span>oportion ",
	"kja6j3obText": "of patients who withdrew ",
	"kja6j3ocText": "for any reason)",
	"kja6j3odText": "Back",
	"kja6j3oeText": "P<span class=\"_ _2\"></span>roduct (studies)",
	"kja6j3ofText": "Brintellix® (n=15) <br>Agomelatine (n=23)<span class=\"_ _0\"></span> <br>Amitriptyline (n=96) <br><span class=\"wsc\">Bupropion(n=33) <br></span>Citalopram (n=38)<span class=\"_ _0\"></span> <br>Clomipramine (n=20) <br>Desvenlafaxine (n=9) <br>Duloxetine (n=30)<span class=\"_ _0\"></span> <br>Escitalopram (n=42) <br>Fluoxetine (n=117) <br>Fluvoxamine (n=32)",
	"kja6j3ogText": "Levomilnacipram (n=6) <br>Milnacipran (n=10) <br>Mirtazapine (n=34) <br>Nefazodone (n=21)<span class=\"_ _0\"></span> <br>P<span class=\"_ _c\"></span>aroxetine (n=114) <br>Reboxetine (n=17) <br>Sertraline (n=54) <br>T<span class=\"_ _c\"></span>razodone (n=26)<span class=\"_ _0\"></span> <br>Venlafaxine (n=68) <br>Vilazodone (n=9) ",
	"kja6j3ohText": "Vs. placebo <br>or active<span class=\"_ _0\"></span> <br><span class=\"ls29 wsa3\">comparator</span>",
	"kja6j3oiText": "Key inclusion criteria for the studies<div style=\"line-height:1.2;\"><span class=\"ff3 ls38 ws7e\">• Double<span class=\"_ _0\"></span>-blind, randomised controlled trials (RCTs)<br><span class=\"ls36 wsb\">   comparing antidepressants with placebo or another</span><br><span class=\"ls36 wsb\">   active antidepressant as oral monotherapy.</span></span></div>",
	"kja6j3ojText": "<div style=\"line-height: 1.2;\">• Pat<span class=\"_ _2\" style=\"\"></span>ients we<span class=\"_ _2\"></span>re acute<span class=\"_ _2\"></span>ly tre<span class=\"_ _2\"></span>ated a<span class=\"_ _2\"></span>dults (<span class=\"_ _c\"></span>≥<span class=\"_ _3\"></span>1<span class=\"_ _2\"></span>8 ye<span class=\"_ _2\"></span>ars old a<span class=\"_ _2\"></span>nd of bot<span class=\"_ _2\"></span>h<br>   sex<span class=\"_ _2\"></span>es<span class=\"_ _c\"></span>) with a prima<span class=\"_ _2\"></span>ry diagn<span class=\"_ _2\"></span>osis o<span class=\"_ _2\"></span>f maj<span class=\"_ _2\"></span>or dep<span class=\"_ _2\"></span>ressiv<span class=\"_ _2\"></span>e diso<span class=\"_ _2\"></span>rde<span class=\"_ _2\"></span>r <br><span class=\"ls37 ws7d\">   according<span class=\"_ _0\" style=\"\"></span> to s<span class=\"_ _0\"></span>t<span class=\"_ _0\"></span>andard op<span class=\"_ _0\"></span>erat<span class=\"_ _0\"></span>ionalised diagn<span class=\"_ _0\"></span>os<span class=\"_ _0\"></span>tic c<span class=\"_ _0\"></span>riter<span class=\"_ _0\"></span>ia.</span></div>",
	"kja6j3okText": "A systematic rev<span class=\"_ _2\"></span>iew and network meta-an<span class=\"_ _2\"></span>alysis was performed usi<span class=\"_ _2\"></span>ng group-le<span class=\"_ _2\"></span>vel data. A network meta-ana<span class=\"_ _2\"></span>lysis of on<span class=\"_ _2\"></span>ly head-to-head studi<span class=\"_ _2\"></span>es includ<span class=\"_ _2\"></span>ed a single d<span class=\"_ _2\"></span>irect study <br>comparison of Bri<span class=\"_ _2\"></span>ntelli<span class=\"_ _2\"></span>x® (v<span class=\"_ _2\"></span>ortioxetine<span class=\"_ _c\"></span>) at a dose of 1<span class=\"_ _c\"></span>0 mg/da<span class=\"_ _2\"></span>y and ven<span class=\"_ _2\"></span>lafaxine at a dose o<span class=\"_ _2\"></span>f 1<span class=\"_ _c\"></span>50 mg/d<span class=\"_ _2\"></span>ay<span class=\"_ _2\"></span>.",
	"Brintellix_813d0636ff": "<span class=\"ff2 fc0 fs13\">References</span>",
	"Brintellix_81a5cfc159": "<div class=\"ff3 fc1\" style=\"font-size:15px;\"><span class=\"ff2\">1.</span> Cipriani A et al. Lancet 2018;391:1357-1366.</div>"
}
